Clinical trials
Preeclampsia clinical trials
Below are recruiting preeclampsia clinical trials, each written for real people, not researchers. We’re tracking 109 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05445544Recruiting
Study of belly and baby microbes to improve preeclampsia screening
This study looks at tiny living organisms in pregnancy (and related body samples) to find better ways to screen for preeclampsia. By learning early warning signs, it may help doctors identify risk sooner during routine prenatal care.
Guangzhou, GuangdongAges 18 years+ - NCT05662696Recruiting
Telemonitoring for pregnant people at high risk of preeclampsia
This study tests whether a home telemonitoring program (sending health readings from home) is practical and helpful for people at high risk for preeclampsia. It may help catch warning signs earlier and support safer care during the first half of pregnancy.
Karachi, SindhAges 18 years+ - NCT05676476Recruiting
Tested extra blood-pressure control to extend pregnancy in preeclampsia
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
Birmingham, AlabamaAges 14–49 - NCT05709483RecruitingEarly Phase 1
Aspirin plan test to predict who avoids preeclampsia
This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.
New York, New YorkAges 18–45 - NCT05924971RecruitingPhase 2
Taking aspirin to reduce complications after severe preeclampsia
This trial looks at whether aspirin after delivery can help postpartum recovery in people diagnosed with preeclampsia with severe features during the hospital stay. You might be considered if your care is through specific clinics at Long Beach Memorial.
Long Beach, CaliforniaAges 18 years+ - NCT06033131RecruitingPhase 3
Metformin to help prolong pregnancy in preterm preeclampsia
This trial tests whether metformin, a common diabetes medication, can help women with preeclampsia stay pregnant longer before delivery. If you have been diagnosed with preeclampsia and your doctors are monitoring you without immediate delivery, this study might be an option.
HelsinkiAges 18 years+ - NCT06111079RecruitingPhase 3
Stopping Aspirin in High-Risk Pregnant Women
This trial tests whether stopping aspirin use in high-risk pregnant women can be safe. It aims to find the best time to stop taking aspirin to prevent preeclampsia, a condition that causes high blood pressure during pregnancy.
Guangzhou, GuangdongAges 18–45 - NCT06168461RecruitingEarly Phase 1
Can daily aspirin help after preeclampsia?
This study tests whether taking a low-dose aspirin every day can help improve blood vessel health in people who had preeclampsia within the past 5 years. The goal is to see if aspirin can lower the risk of future heart problems.
Iowa City, IowaAges 18–50 - NCT06232668Recruiting
Studying the placenta in preeclampsia
This study looks at the placenta and the area where the baby meets the mother's body to understand preeclampsia, a serious pregnancy complication. If you are between 9 and 15 weeks pregnant with one baby and are already scheduled for a placenta test, you may be able to join.
Alicante, AlicanteAges 18 years+ - NCT06239363Recruiting
Dietary salicylates and preeclampsia study
This trial looks at how salicylates (compounds in foods like fruits and spices) affect preeclampsia, a pregnancy complication with high blood pressure. It compares healthy pregnant women to those with preeclampsia to understand if diet plays a role.
PoznanAges 18–45 - NCT06339749Recruiting
Pregnancy outcomes in normal vs stage 1 high blood pressure
This study follows pregnant women with normal blood pressure or mild high blood pressure (stage 1) to compare pregnancy outcomes. It helps doctors understand how slightly elevated blood pressure may affect pregnancy.
Guangzhou, GuangdongAges 18–45 - NCT06383858Recruiting
Pre-eclampsia risk screening and prevention study
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
Guangzhou, GuangdongAges 18 years+ - NCT06430398Recruiting
AI Study for Early Preeclampsia Prediction in Pregnancy
This study tests a new artificial intelligence (AI) method that uses multiple types of biological data to predict preeclampsia (a serious pregnancy complication involving high blood pressure) much earlier. It is for women who were once considered high risk for preeclampsia but later found to be low risk, to see if the AI can help detect it even sooner.
Pieve Emanuele, MilanAges 18 years+ - NCT06464159Recruiting
A new treatment for preeclampsia during pregnancy
This study is testing a new treatment strategy for women with preeclampsia, a serious pregnancy condition that causes high blood pressure. If you have preeclampsia or a normal pregnancy, you may be able to join to help find better treatments.
ParisAges 18–50 - NCT04154332Recruiting
Study of pregnancy-related cell signals in preeclampsia
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
Birmingham, AlabamaAges 18–45 - NCT06741436Recruiting
Exercise testing after preeclampsia
This study looks at how the heart and blood vessels work after a pregnancy complicated by preeclampsia. It uses exercise testing to see if there are lasting effects, which may help improve long-term heart health monitoring and care.
Nashville, TennesseeAges 18 years+ - NCT06759545Recruiting
Olive oil for preeclampsia prevention in high-risk pregnancy
This study tests if taking extra virgin olive oil during early pregnancy can reduce the chance of developing preeclampsia. It is designed for women who have one or more conditions that make them more likely to get preeclampsia.
Ashkelon, Ashkelon DistrictAges 18–45 - NCT06791668Recruiting
Magnesium treatment for severe preeclampsia
This study looks at different ways to give magnesium sulphate to women with severe preeclampsia to find the best treatment plan.
CairoAges 18 years+ - NCT06912477Recruiting
Blood vessel health in preeclampsia prognosis
This study looks at blood vessel function in pregnant people with preeclampsia to see if it can help predict outcomes. It involves non-invasive measures and routine blood tests.
HeidelbergAges 18 years+ - NCT06953115Recruiting
Nerve stimulation for mild preeclampsia
This trial tests if using a gentle nerve stimulation device (applied near the neck) can help women with mild preeclampsia. It may offer a non-medication way to manage blood pressure during pregnancy.
Guadalajara, JaliscoAges 18 years+ - NCT07084727Recruiting
Looking for markers of blood vessel damage in preeclampsia
This trial is looking for women with preeclampsia to help find markers in the blood that show how blood vessels are affected. The goal is to better understand the condition and possibly improve future care.
Edegem, AntwerpAges 18–40 - NCT07151339Recruiting
Preventing heart and kidney issues after preeclampsia
This study tests a new approach to prevent long-term heart and kidney problems in people who had preeclampsia, HELLP syndrome, or kidney disease during pregnancy. It aims to see if early follow-up care can improve future health.
KielAges 18 years+ - NCT07183384RecruitingPhase 1/Phase 2
Exosome therapy for blood vessel health after preeclampsia
This study tests whether exosomes from mesenchymal stem cells can help repair the blood vessels after preeclampsia. If you delivered within the last two weeks and had preeclampsia, you may qualify to take part.
Bandung, West JavaAges 18–50 - NCT07193680Recruiting
Managing term preeclampsia with angiogenic factors
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
Barcelona, BARCELONAAges 18 years+
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for preeclampsia?
- Yes. Clin2 currently lists 109 recruiting preeclampsia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a preeclampsia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a preeclampsia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.